Verrica Pharmaceuticals Inc. (NASDAQ: VRCA)
$8.34
-0.1800 ( -2.11% ) 138.8K
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Market Data
Open
$8.34
Previous close
$8.52
Volume
138.8K
Market cap
$355.06M
Day range
$8.12 - $8.57
52 week range
$2.86 - $11.41
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 26, 2023 |
4 | Insider transactions | 1 | Dec 19, 2023 |
4 | Insider transactions | 1 | Nov 16, 2023 |
4 | Insider transactions | 1 | Nov 16, 2023 |
4 | Insider transactions | 1 | Nov 16, 2023 |
4 | Insider transactions | 1 | Nov 16, 2023 |
4 | Insider transactions | 1 | Nov 16, 2023 |
8-k | 8K-related | 14 | Nov 09, 2023 |
10-q | Quarterly Reports | 66 | Nov 09, 2023 |
4 | Insider transactions | 1 | Aug 28, 2023 |